moxonidine has been researched along with Focal Segmental Glomerulosclerosis in 2 studies
moxonidine: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amann, K | 1 |
| Rump, LC | 1 |
| Simonaviciene, A | 1 |
| Oberhauser, V | 1 |
| Wessels, S | 1 |
| Orth, SR | 1 |
| Gross, ML | 1 |
| Koch, A | 1 |
| Bielenberg, GW | 1 |
| VAN Kats, JP | 1 |
| Ehmke, H | 1 |
| Mall, G | 2 |
| Ritz, E | 2 |
| Irzyniec, T | 1 |
| Greber, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System[NCT03109795] | Phase 4 | 30 participants (Actual) | Interventional | 2017-04-10 | Terminated (stopped due to Funding ended) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for moxonidine and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats.
Topics: Albuminuria; Angiotensin II; Animals; Antihypertensive Agents; Glomerulosclerosis, Focal Segmental; | 2000 |
Beneficial effect of nifedipine and moxonidine on glomerulosclerosis in spontaneously hypertensive rats. A micromorphometric study.
Topics: Animals; Antihypertensive Agents; Blood Vessels; Glomerulosclerosis, Focal Segmental; Imidazoles; Ki | 1992 |